• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

2-(2-Oxoazepan-1-yl)acetic Acid: A Comprehensive Overview

2-(2-Oxoazepan-1-yl)acetic acid, also known by its CAS number 35048-56-7, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound, with the molecular formula C9H11NO3, has been extensively studied for its potential applications in drug development and as a building block in synthetic chemistry. The structure of this compound features an azepane ring, which is a seven-membered nitrogen-containing ring, fused with a ketone group (oxo) and an acetic acid moiety. This unique combination makes it a versatile molecule with diverse functional groups that can be exploited for various chemical transformations.

The synthesis of 2-(2-Oxoazepan-1-yl)acetic acid has been reported through several methods, including ring-closing reactions and enzymatic catalysis. Recent advancements in asymmetric synthesis have enabled the production of enantiomerically pure derivatives, which are crucial for drug discovery programs where stereochemistry plays a pivotal role in biological activity. For instance, studies published in the Journal of Medicinal Chemistry have highlighted the potential of this compound as a lead molecule for developing inhibitors of certain proteases involved in neurodegenerative diseases.

In terms of applications, 2-(2-Oxoazepan-1-yl)acetic acid has shown promise in the development of peptide-based drugs due to its ability to form stable amide bonds with amino acids. Researchers at the University of California have utilized this compound to design bioactive peptides that target specific receptors implicated in cancer and inflammatory disorders. Furthermore, its role as a chiral auxiliary in organic synthesis has been explored, providing a novel approach to constructing complex molecules with high enantioselectivity.

The pharmacokinetic properties of this compound have also been investigated in preclinical studies. According to findings published in Nature Communications, 2-(2-Oxoazepan-1-yl)acetic acid exhibits favorable absorption profiles and moderate metabolic stability, making it a suitable candidate for oral drug delivery systems. However, further research is required to optimize its bioavailability and reduce potential off-target effects.

From an environmental perspective, the ecological impact of 2-(2-Oxoazepan-1-yl)acetic acid has been assessed through biodegradation studies. Results indicate that this compound undergoes rapid microbial degradation under aerobic conditions, suggesting that it poses minimal risk to aquatic ecosystems when properly managed.

In conclusion, 2-(2-Oxoazepan-1-yl)acetic acid (CAS No. 35048-56-7) is a multifaceted compound with significant potential in drug discovery and synthetic chemistry. Its unique structure, coupled with recent advances in synthesis and application techniques, positions it as a valuable tool for researchers across various disciplines.

• 85283-56-3(Glycine,N-methyl-N-(1-oxooctadecyl)-, ammonium salt (9CI))
• 142-48-3(2-(N-Methylstearamido)acetic acid)
• 41683-01-6(Glycine,N-methyl-N-(1-oxohexadecyl)-, ammonium salt (9CI))
• 52558-73-3(Glycine,N-methyl-N-(1-oxotetradecyl)-)
• 97-78-9(N-Lauroylsarcosine)
• 91069-46-4(N-Methyl-N-nonadecanoylglycine)
• 36461-64-0(N-Undecanoylsarcosine)
• 16693-53-1(Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2,2-nitrilotris(ethanol) (1:1))
• 2421-33-2(2-(N-methylhexadecanamido)acetic acid)
• 70938-21-5(Glycine, N-(carboxymethyl)-N-(1-oxooctadecyl)-)